Astellas Pharma, Inc. Financials

Market Capitalization ¥2.761 Trillion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	50.51
Forward PE	20.36
Price to Sales TTM	¥1.56
Price to Book MRQ	¥1.80
Enterprise to Revenue	1.92
Enterprise to EBITDA	9.30

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-03-31
Profit Margin	3.09%
Operating Margin	8.22%
Return on Assets TTM	3.03%
Return on Equity TTM	3.45%

Income Statement

Revenue TTM	¥1,772,155,043,840
Revenue per Share TTM	¥989.13
Quarterly Revenue Growth	17.90%
Gross Profit TTM	¥1,311,187,000,000
EBITDA	¥180,939,000,000
Net Income to Common TTM	¥54,746,001,408
Diluted EPS TTM	¥30.54
Quarterly Earnings Growth YoY	1239.40%

Balance Sheet

Total Cash MRQ	¥292,993,007,616
Total Cash per Share MRQ	¥163.67
Total Debt MRQ	¥
Total Debt to Equity MRQ	61.17
Current Ratio MRQ	1.10
Book Value per Share MRQ	¥854.61

Cash Flow

Operating Cash Flow TTM	¥200,804,007,936
Levered Free Cash Flow TTM	¥132,658,503,680

4503 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,789,859,968
Float Shares	1,789,820,998
Avg 10 Volume	5,616,690
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.25%
% Held by Institutions	52.08%

Stock Price Summary

Beta	0.22
Fifty Two Week Low	¥1426.00
Fifty Two Week High	¥1835.00
Fifty Two Week Change	-14.02%
Day 50 MA	¥1659.42
Day 200 MA	¥1637.07

Dividends and Splits

Forward Annual Dividend Rate	¥74.00
Forward Annual Dividend Yield	4.93%
Trailing Annual Dividend Rate	¥72.00
Trailing Annual Dividend Yield	4.79%
Payout Ratio	236.22%
Dividend Date
Ex Dividend Date	2025-03-28
Last Split Factor
Last Split Date	2014-03-27